Opioid Antidote Price Hikes Cost Taxpayer Millions, Senators Say

(Bloomberg) -- Kaleo Inc.’s more than 600 percent price increase on its opioid-overdose antidote has cost the Medicare and Medicaid health program $142 million since 2014, according to a report by ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.